Cardiol Therapeutics Inc.
CRDL.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.89M | -26.99M | -25.77M | -26.80M | -26.57M |
| Total Depreciation and Amortization | 89.00K | 217.80K | 244.60K | 272.90K | 287.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.87M | 9.68M | 8.14M | 8.91M | 7.49M |
| Change in Net Operating Assets | 635.20K | -872.90K | -786.60K | -703.80K | -280.50K |
| Cash from Operations | -17.30M | -17.97M | -18.17M | -18.32M | -19.07M |
| Capital Expenditure | -19.60K | -23.20K | -21.30K | -15.60K | -19.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.60K | -23.20K | -21.30K | -15.60K | -19.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -55.20K | -46.00K | -41.40K | -41.40K | -41.40K |
| Issuance of Common Stock | 21.39M | 21.39M | 21.44M | 21.53M | 177.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.65M | -2.65M | -2.65M | -2.65M | -- |
| Cash from Financing | 13.35M | 13.35M | 13.40M | 13.46M | 100.10K |
| Foreign Exchange rate Adjustments | 933.30K | 405.20K | 920.10K | 1.36M | 861.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.04M | -4.23M | -3.87M | -3.51M | -18.13M |